TheEdgeResearch
Home / Stocks / RSCI

Redwood Scientific Technologies, Inc. (RSCI)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$17
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-3.03
52-Wk Range
0.0001-0.0111
CEO
Jason Cardiff
Country
US
Currency
USD

Redwood Scientific Technologies, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Albany, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $17. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of -3.03 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.00
Price / Book
-0.10
EV / EBITDA
0.08
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.60
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2016-09-08
Headquarters
Albany, NY, US
About Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.

Comparable companies

Redwood Scientific Technologies, Inc. is most often compared with the following Healthcare names:

AAXTCANQFETAOFGENXISHIMILCNXGBSYUPTBETTHMO
More research on RSCI
RSCI technical analysis RSCI TheEdge Score Compare against peers
Open full interactive analysis & DCF →